Your browser doesn't support javascript.

Biblioteca Virtual en Salud

Hipertensión

Home > Búsqueda > ()
XML
Imprimir Exportar

Formato de exportación:

Exportar

Email
Adicionar mas contactos
| |

Swarm Learning as a privacy-preserving machine learning approach for disease classification

Stefanie Warnat-Herresthal; Hartmut Schultze; Krishna Prasad Lingadahalli Shastry; Sathyanarayanan Manamohan; Saikat Mukherjee; Vishesh Garg; Ravi Sarveswara; Kristian Haendler; Peter Pickkers; N Ahmad Aziz; Sofia Ktena; Christian Siever; Michael Kraut; Milind Desai; Bruno Monet; Maria Saridaki; Charles Martin Siegel; Anna Drews; Melanie Nuesch-Germano; Heidi Theis; Mihai G Netea; Fabian J Theis; Anna C Aschenbrenner; Thomas Ulas; Monique M.B. Breteler; Evangelos J Giamarellos-Bourboulis; Matthijs Kox; Matthias Becker; Sorin Cheran; Michael S Woodacre; Eng Lim Goh; Joachim L. Schultze; - German COVID-19 OMICS Initiative (DeCOI).
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-171009
Identification of patients with life-threatening diseases including leukemias or infections such as tuberculosis and COVID-19 is an important goal of precision medicine. We recently illustrated that leukemia patients are identified by machine learning (ML) based on their blood transcriptomes. However, there is an increasing divide between what is technically possible and what is allowed because of privacy legislation. To facilitate integration of any omics data from any data owner world-wide without violating privacy laws, we here introduce Swarm Learning (SL), a decentralized machine learning approach uniting edge computing, blockchain-based peer-to-peer networking and coordination as well as privacy protection without the need for a central coordinator thereby going beyond federated learning. Using more than 14,000 blood transcriptomes derived from over 100 individual studies with non-uniform distribution of cases and controls and significant study biases, we illustrate the feasibility of SL to develop disease classifiers based on distributed data for COVID-19, tuberculosis or leukemias that outperform those developed at individual sites. Still, SL completely protects local privacy regulations by design. We propose this approach to noticeably accelerate the introduction of precision medicine.